Clinical features and outcomes of unresectable locally advanced lung adenocarcinoma with uncommon <i>EGFR</i> mutations: a retrospective multi-center Chinese study.

Transl Lung Cancer Res · 2025 · PMC11826267 · PMID 39958229

Europe PMC DOI

hedged sentence

0.4900

closest p · 9.8× alpha

0.4900

boldest claim

The sentences

showed a trendP=0.49not close (p > 0.1)

Compared to EGFR -TKIs, both CRT and RT combined with TKIs significantly improved PFS (P=0.02, 0.04, respectively), and showed a trend toward superior OS compared to EGFR -TKIs (P=0.49, 0.06, respectively).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.